Future Virology (ISSN 1746-0794) is a monthly, international peer-reviewed journal published by Future Medicine Ltd in the United Kingdom, dedicated to advancing the frontiers of virological research with a strong emphasis on translational medicine and clinical applications. As a subscription-based publication indexed in the Science Citation Index (SCI), the journal covers a comprehensive scope of topics, including viral pathogenesis, vaccine development, antiviral therapies, and emerging viral technologies, thereby serving as a vital resource for researchers, clinicians, and scientists in related biomedical fields. While the journal maintains a rigorous review process and high editorial standards, it is currently not included in the Chinese Academy of Sciences (CAS) journal ranking system, and its impact factor, which varies by year, should be verified against the latest Journal Citation Reports (JCR) data. Despite its specialized nature and relatively lower submission competition compared to broader high-impact journals, Future Virology offers a reputable platform for disseminating innovative findings, though authors should consider the potential fluctuations in impact factor when evaluating its standing in academic assessments.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com